SEC inquiry sacks home health stocks

Shares of home health providers sank Wednesday as an investigation into the industry's Medicare reimbursement practices expanded.
JUN 29, 2010
Shares of home health providers sank Wednesday as an investigation into the industry's Medicare reimbursement practices expanded. After the markets closed on Tuesday, LHC Group Inc. and Gentiva Health Services Inc. said they are being investigated by the Securities and Exchange Commission. LHC said the agency told it to preserve all documents related to its Medicare reimbursement practices. According to LHC, the agency will ask it to submit those documents for review. That brings the number of home health care companies that the SEC is scrutinizing to four, as it started investigations into Amedisys Inc. and Almost Family Inc. on July 1. This spring the Senate Finance Committee started looking into reports that the four companies manipulated the number of visits they made to patients to get more money from Medicare. They allegedly made extra visits to patients to bump them up to a higher reimbursement level: when they visit patients 10 times, the companies are reimbursed an additional $2,200 per patient. In a note to clients, analyst Kevin Ellich of RBC Capital Markets downgraded LHC Group shares to "Sector Perform" from "Outperform," saying physicians, therapists, clients and companies may cut back on business with LHC because of the investigation. Ellich lowered his 2010 and 2011 profit estimates for LHC and trimmed his price target to $25 per share from $30. "History has shown us that other providers billed government sources more conservatively when scrutinized for "upcoding" or billing too aggressively and we believe this dynamic could follow suit in the home health industry," he said. LHC stock dipped 77 cents, or 3.3 percent, to $22.25 in afternoon trading. Robert W. Baird and Co. analyst Whit Mayo downgraded Amedisys shares to "Neutral" from "Outperform," saying the company's business went into a slump in June. "We believe the slew of recent regulatory criticisms may be weighing much more heavily on the business than we expected," Mayo said. He noted that Gentiva has not disclosed a slowdown in business and LHC has backed its profit and revenue outlook for the year. He maintained an "Outperform" rating on both companies. Amedisys shares lost 79 cents, or 3 percent, to $25.78. Almost Family stock slid $1.42, or 5.4 percent, to $24.94, and shares of Gentiva fell 47 cents, or 2.1 percent, to $21.83.

Latest News

Advisor moves: Atlas tops $1B as Wells Fargo, UBS add bank veterans
Advisor moves: Atlas tops $1B as Wells Fargo, UBS add bank veterans

Wells Fargo adds two bank-channel recruits, UBS lands a JPMorgan Chase veteran, and a multi-family office lifts Atlas past $1B

Advisor mom’s son used her password to log into clients’ accounts, sell deal with conflicts, according to Washington state
Advisor mom’s son used her password to log into clients’ accounts, sell deal with conflicts, according to Washington state

“The state comes down on you in years when you make 40% returns for clients,” said Bill Swayne, the advisor and son of Candace Swayne.

Osaic in talks with Anthropic as AI reshapes advisor workforce
Osaic in talks with Anthropic as AI reshapes advisor workforce

The Independent broker-dealer giant has had “active conversations” with the Claude maker, which is days away from its expected IPO

The retirement milestone advisors aren't tracking
The retirement milestone advisors aren't tracking

For Gen X clients entering life after work, answering the financial question isn't enough to solve the entire retirement equation.

Wealthtech firms target stock pay, pensions and heirs for advisors
Wealthtech firms target stock pay, pensions and heirs for advisors

Tools from Grantd, Income Lab and Healthspan Wealth aim to keep RIAs involved in clients’ biggest money decisions

SPONSORED Best Practices for Engaging Women Around Alternatives

Growing wealth, evolving priorities, and untapped opportunities are reshaping how women approach long-term investing.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.